Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

pharma marketing

Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and Treated
Posted in
  • Digital Transformation

Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and Treated

Pharmaceutical marketing has always tried to reach the right doctor and the right patient at the … Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and TreatedRead more

by Krishna Aggarwal•April 4, 2026April 4, 2026•0
When a Drug Loses Its Patent, Marketing Becomes Defense, Not Growth
Posted in
  • Strategy & Execution

When a Drug Loses Its Patent, Marketing Becomes Defense, Not Growth

Pharmaceutical companies do not lose billions when a patent expires. They lose billions in the years … When a Drug Loses Its Patent, Marketing Becomes Defense, Not GrowthRead more

by Krishna Aggarwal•April 4, 2026April 4, 2026•0
The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy
Posted in
  • Regulatory Compliance
  • Uncategorized

The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy

Drug price transparency laws are not just policy changes. They are forcing pharmaceutical companies to change … The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing StrategyRead more

by Krishna Aggarwal•April 2, 2026April 2, 2026•0
The Truth About Pharmaceutical Marketing in the United States
Posted in
  • Industry Landscape
  • Your POV

The Truth About Pharmaceutical Marketing in the United States

In most industries, marketing influences preference. In the United States pharmaceutical industry, marketing influences diagnosis, treatment … The Truth About Pharmaceutical Marketing in the United StatesRead more

by Krishna Aggarwal•April 2, 2026April 2, 2026•0
Specialty Pharmacy Distribution Strategies
Posted in
  • Industry Landscape

Specialty Pharmacy Distribution Strategies

Specialty pharmacy distribution has become the backbone of modern pharmaceutical commercialization. Biologics, gene therapies, and high-cost … Specialty Pharmacy Distribution StrategiesRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
How to Handle Payer Rejections
Posted in
  • Industry Landscape

How to Handle Payer Rejections

Payer rejections whether in the form of prior authorization denials, formulary exclusions, or claim rejections have … How to Handle Payer RejectionsRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
Copay Assistance Programs: Complete Guide
Posted in
  • Industry Landscape

Copay Assistance Programs: Complete Guide

Copay assistance programs have become one of the most influential—and controversial—tools in pharmaceutical access. They sit … Copay Assistance Programs: Complete GuideRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
Understanding Pharmacy Benefit Managers (PBMs)
Posted in
  • Industry Landscape

Understanding Pharmacy Benefit Managers (PBMs)

Pharmacy Benefit Managers (PBMs) sit at the center of the modern pharmaceutical ecosystem. They influence which … Understanding Pharmacy Benefit Managers (PBMs)Read more

by Ritu Negi•March 18, 2026March 18, 2026•0
How to Position Your Drug on Formularies
Posted in
  • Industry Landscape

How to Position Your Drug on Formularies

Formulary positioning has become the single most decisive factor in pharmaceutical market success. In modern healthcare … How to Position Your Drug on FormulariesRead more

by Ritu Negi•March 18, 2026March 18, 2026•0
Health Economics and Outcomes Research (HEOR) for Sales Reps
Posted in
  • Industry Landscape

Health Economics and Outcomes Research (HEOR) for Sales Reps

Health Economics and Outcomes Research (HEOR) has moved from a back-office analytics function to a frontline … Health Economics and Outcomes Research (HEOR) for Sales RepsRead more

by Ritu Negi•March 18, 2026March 18, 2026•0

Posts pagination

1 2 … 24 Next

Recent Posts

  • The Silent Architects: How Private Equity Is Rewriting the Rules of Pharmaceutical Commercialization
  • Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and Treated
  • When a Drug Loses Its Patent, Marketing Becomes Defense, Not Growth
  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A